fromIPWatchdog.com | Patents & Intellectual Property Law
3 months agoFTC Renews Campaign to Remove 'Junk' Inhaler and Device Patents from Orange Book Listings
FTC's warning letters may lead to extended litigation over patent listings.
The agency aims to improve access to generic drugs by challenging patents.
Targeted patents in the pharmaceutical sector are under scrutiny.
Efforts continue irrespective of longstanding industry calls for clearer guidelines.